HEPATITIS B CORE ANTIBODY POSITIVE

This adverse event was reported 377 times

These drugs are most commonly taken by patients reporting HEPATITIS B CORE ANTIBODY POSITIVE:

# Drug Count
0 HUMAN IMMUNOGLOBULIN G 89
1 RITUXIMAB 45
2 METHOTREXATE SODIUM 42
3 METHOTREXATE 36
4 PREDNISONE 35
5 ADALIMUMAB 26
6 CYCLOPHOSPHAMIDE 24
7 CYCLOPHOSPHAMIDE FOR INJECTION 24
8 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 24
9 INFLIXIMAB 24
See all common drugs associated with HEPATITIS B CORE ANTIBODY POSITIVE

HEPATITIS B CORE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 15 0.0282
1 DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE 2 0.0064
2 HUMAN IMMUNOGLOBULIN G 89 0.0043
3 PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION 3 0.0025
4 ADEFOVIR DIPIVOXIL 3 0.0024
5 BETAXOLOL HYDROCHLORIDE 1 0.0019
6 PILOCARPINE HYDROCHLORIDE 4 0.0016
7 PYRIDOSTIGMINE BROMIDE ORAL 5 0.0014
8 ISONIAZID 20 0.0012
9 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 6 0.0009
See all drugs enriched for association with HEPATITIS B CORE ANTIBODY POSITIVE